Nothing Special   »   [go: up one dir, main page]

Li et al., 2021 - Google Patents

PARK genes link mitochondrial dysfunction and alpha-synuclein pathology in sporadic Parkinson's disease

Li et al., 2021

View HTML
Document ID
3289781018190765005
Author
Li W
Fu Y
Halliday G
Sue C
Publication year
Publication venue
Frontiers in Cell and Developmental Biology

External Links

Snippet

Parkinson's disease (PD) is an age-related neurodegenerative disorder affecting millions of people worldwide. The disease is characterized by the progressive loss of dopaminergic neurons and spread of Lewy pathology (α-synuclein aggregates) in the brain but the …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Similar Documents

Publication Publication Date Title
Li et al. PARK genes link mitochondrial dysfunction and alpha-synuclein pathology in sporadic Parkinson’s disease
Farrer Genetics of Parkinson disease: paradigm shifts and future prospects
Barodia et al. Parkin and PINK1 functions in oxidative stress and neurodegeneration
O’Hara et al. LRRK2 and α-synuclein: distinct or synergistic players in Parkinson’s disease?
Hatano et al. Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease
Giráldez-Pérez et al. Models of α-synuclein aggregation in Parkinson’s disease
Kitada et al. Absence of nigral degeneration in aged parkin/DJ‐1/PINK1 triple knockout mice
Hardy et al. Genes and parkinsonism
Mullin et al. α-Synuclein and mitochondrial dysfunction in Parkinson’s disease
Cresto et al. The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
Perfeito et al. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
Benskey et al. The contribution of alpha synuclein to neuronal survival and function–Implications for Parkinson's disease
Burbulla et al. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease
Picconi et al. Synaptic dysfunction in Parkinson’s disease
Li et al. The role of the LRRK2 gene in Parkinsonism
Abou-Sleiman et al. Expanding insights of mitochondrial dysfunction in Parkinson's disease
Fahn et al. Neurodegeneration and neuroprotection in Parkinson disease
Perfeito et al. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
und Halbach et al. Genes, proteins, and neurotoxins involved in Parkinson’s disease
Hoepken et al. Parkinson patient fibroblasts show increased alpha-synuclein expression
Götz et al. What renders TAU toxic
Esteves et al. Mitochondrial dysfunction: the road to alpha‐synuclein oligomerization in PD
Tanji et al. p 62 Deficiency Enhances α‐Synuclein Pathology in Mice
Horowitz et al. Gene–environment interactions in Parkinson's disease: the importance of animal modeling
Hattori et al. Twenty years since the discovery of the parkin gene